Jihong Liu Selected Research

Ovarian Epithelial Carcinoma

1/2021	The impact of lymph node dissection on survival in patients with clinical early-stage ovarian cancer.
1/2021	Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial.
9/2020	Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept.
1/2015	GOLPH3L is a Novel Prognostic Biomarker for Epithelial Ovarian Cancer.
1/2012	Screening and identification of biomarkers in ascites related to intrinsic chemoresistance of serous epithelial ovarian cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jihong Liu Research Topics

Disease

58	Neoplasms (Cancer) 11/2022 - 04/2003
23	Prostatic Neoplasms (Prostate Cancer) 07/2022 - 03/2010
22	Ovarian Neoplasms (Ovarian Cancer) 12/2022 - 07/2009
17	Erectile Dysfunction 06/2022 - 01/2016
14	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 09/2004
11	Fibrosis (Cirrhosis) 06/2022 - 01/2016
7	Diabetes Mellitus 06/2022 - 08/2013
7	Infections 01/2022 - 09/2004
7	Carcinoma (Carcinomatosis) 01/2022 - 03/2007
7	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2021 - 01/2016
7	Urolithiasis 01/2019 - 04/2003
6	Neoplasm Metastasis (Metastasis) 11/2020 - 10/2011
6	Calculi (Calculus) 01/2017 - 04/2003
5	Disease Progression 12/2022 - 01/2020
5	Chemical and Drug Induced Liver Injury 12/2022 - 01/2021
5	Inflammation (Inflammations) 07/2022 - 01/2020
5	COVID-19 02/2022 - 01/2020
5	Ovarian Epithelial Carcinoma 01/2021 - 01/2012
5	Ischemia 01/2021 - 04/2011
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 07/2013
5	Obesity 12/2020 - 01/2015
5	Body Weight (Weight, Body) 01/2020 - 01/2004
4	Reperfusion Injury 12/2022 - 09/2019
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2014
4	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 04/2013
4	Asthma (Bronchial Asthma) 11/2017 - 07/2012
4	Urinary Calculi (Urinary Calculus) 01/2017 - 12/2011
4	Hydronephrosis 12/2011 - 10/2009
3	Kidney Calculi (Kidney Stone) 01/2022 - 05/2012
3	Lymphatic Metastasis 01/2021 - 11/2005
3	Ischemic Stroke 10/2020 - 08/2002
3	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2015
3	Premature Birth (Birth, Premature) 01/2020 - 02/2011
3	Prostatitis 01/2019 - 04/2004
3	Pain (Aches) 01/2019 - 07/2016
3	Atrophy 01/2019 - 01/2018
3	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2015
2	Anemia 12/2022 - 01/2021
2	Nausea 12/2022 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 01/2015
2	Stroke (Strokes) 01/2022 - 01/2017

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2011
13	Biomarkers (Surrogate Marker)IBA 04/2021 - 03/2010
11	PlatinumIBA 12/2022 - 08/2007
11	Androgen Receptors (Androgen Receptor)IBA 07/2022 - 09/2011
10	Streptozocin (Streptozotocin)FDA Link 02/2022 - 01/2016
10	AndrogensIBA 01/2021 - 09/2011
7	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2013
7	Biological ProductsIBA 01/2021 - 08/2004
7	Calcium OxalateIBA 11/2016 - 04/2003
6	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 09/2014
6	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 10/2017
6	Messenger RNA (mRNA)IBA 11/2020 - 04/2011
5	VaccinesIBA 11/2021 - 12/2019
4	Peroxynitrous Acid (Peroxynitrite)IBA 12/2022 - 12/2019
4	BerberineIBA 01/2022 - 11/2019
4	Apomorphine FDA Link 01/2022 - 01/2019
4	Indicators and Reagents (Reagents)IBA 01/2022 - 04/2011
4	Fluorescent Dyes (Fluorescent Probes)IBA 11/2021 - 01/2021
4	Testosterone (Sustanon)FDA Link 10/2021 - 01/2016
4	AntigensIBA 01/2021 - 09/2012
3	olaparibIBA 12/2022 - 01/2021
3	CalciumIBA 01/2022 - 10/2008
3	CollagenIBA 01/2022 - 01/2019
3	Pharmaceutical PreparationsIBA 01/2022 - 02/2013
3	fluzoparibIBA 01/2022 - 06/2020
3	Superoxides (Superoxide)IBA 01/2021 - 09/2019
3	Therapeutic UsesIBA 01/2021 - 08/2013
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 02/2011
3	UbiquitinIBA 01/2021 - 05/2016
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021 - 02/2020
3	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021 - 01/2020
3	AntioxidantsIBA 10/2020 - 01/2017
3	Angiogenesis InhibitorsIBA 12/2019 - 07/2013
3	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2017 - 01/2016
3	CholesterolIBA 10/2017 - 01/2013
3	Docetaxel (Taxotere)FDA Link 03/2017 - 02/2011
3	DNA (Deoxyribonucleic Acid)IBA 11/2015 - 06/2011
3	glutamyl carboxylase (gamma-glutamyl carboxylase)IBA 01/2010 - 04/2003
2	CateninsIBA 11/2022 - 11/2020
2	Liraglutide FDA Link 07/2022 - 01/2020
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2022 - 01/2017
2	HMGB1 Protein (HMG1)IBA 06/2022 - 10/2020
2	MicroRNAs (MicroRNA)IBA 02/2022 - 11/2016
2	Angiotensin-Converting Enzyme 2IBA 02/2022 - 01/2020
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2022 - 01/2021
2	niraparibIBA 01/2022 - 01/2020
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 10/2021

Therapy/Procedure

35	Therapeutics 02/2022 - 07/2009
12	Drug Therapy (Chemotherapy) 01/2022 - 07/2009
12	Castration 01/2021 - 06/2014
9	Neoadjuvant Therapy 01/2021 - 02/2011
6	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 02/2011
6	Nephrectomy 10/2013 - 04/2003
5	Adjuvant Chemotherapy 03/2017 - 04/2013
3	Cytoreduction Surgical Procedures 01/2022 - 01/2015
3	Transplantation 01/2021 - 04/2011
3	Lasers (Laser) 03/2018 - 04/2011
3	Hysterectomy 12/2015 - 02/2011
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2022 - 04/2017